Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells

Science

Volumn 275, Issue 5302, 1997, Pages 977-979

  Smiley, Stephen T ^a   Kaplan, Mark H ^a   Grusby, Michael J ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; IMMUNOGLOBULIN D ANTIBODY; IMMUNOGLOBULIN E; INTERLEUKIN 4; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL SECRETION; EMBRYO; FLOW CYTOMETRY; GENE DELETION; GENE LOCUS; GENE SEQUENCE; GENE TARGETING; HELPER CELL; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; SOUTHERN BLOTTING; STEM CELL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES; ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS, CD1; ANTIGENS, CD3; BETA 2-MICROGLOBULIN; CELLS, CULTURED; GENE TARGETING; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-4; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, ANTIGEN, T-CELL; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; TH2 CELLS;

ANIMALIA;

EID: 0031028170     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.275.5302.977     Document Type: Article

References (33)

1. R. Kühn, K. Rajewsky, W. Müller, Science 254, 707 (1991); M. Kopf et al., Nature 362, 245 (1993).
2. R. Kühn, K. Rajewsky, W. Müller, Science 254, 707 (1991); M. Kopf et al., Nature 362, 245 (1993).
3. M. H. Kaplan, U. Schindler, S. T. Smiley, M. J. Grusby, Immunity 4, 313 (1996).
4. K. Shimoda et al., Nature 380, 630 (1996); K. Takeda et al., ibid., p. 627.
5. K. Shimoda et al., Nature 380, 630 (1996); K. Takeda et al., ibid., p. 627.
6. M. A. Brown et al., Cell 50, 809 (1987).
7. R. A. Seder et al., J. Immunol. 148, 1652 (1992).
8. D. A. Ferrick et al., Nature 373, 255 (1995).
9. H. Arase, N. Arase, K. Nakagawa, R. A. Good, K. Onoe, Eur. J. Immunol. 23, 307 (1993).
10. T. Yoshimoto and W. E. Paul, J. Exp. Med. 179, 1285 (1994).
11. T. Yoshimoto, A. Bendelac, J. Hu-Li, W. E. Paul, Proc. Natl. Acad. Sci. U.S.A. 92, 11931 (1995).
12. T. Yoshimoto, A. Bendelac, C. Watson, J. Hu-Li, W. E. Paul, Science 270, 1845 (1995).
13. D. Cosgrove et al., Cell 66, 1051 (1991); M. J. Grusby, R. S. Johnson, V. E. Papaioannou, L. H. Glimcher, Science 253, 1417 (1991).
14. D. Cosgrove et al., Cell 66, 1051 (1991); M. J. Grusby, R. S. Johnson, V. E. Papaioannou, L. H. Glimcher, Science 253, 1417 (1991).
15. S. Cardell et al., J. Exp. Med. 182, 993 (1995).
16. A. Bendelac, N. Killeen, D. R. Littman, R. H. Schwartz, Science 263, 1774 (1994).
17. M. C. Coles and D. H. Raulet, J. Exp. Med. 180, 395 (1994); A. Bendelac, ibid. 182, 2091 (1995).
18. M. C. Coles and D. H. Raulet, J. Exp. Med. 180, 395 (1994); A. Bendelac, ibid. 182, 2091 (1995).
19. H. Arase, N. Arase, K. Ogasawara, R. A. Good, K. Onoe, Proc. Natl. Acad. Sci. U.S.A. 89, 6506 (1992).
20. O. Lantz and A. Bendelac, J. Exp. Med. 180, 1097 (1994).
21. A. Bendelac et al., Science 268, 863 (1995).
22. A. Bradbury, K. T. Belt, T. M. Neri, C. Milstein, F. Calabi, EMBO J. 7, 3081 (1988).
23. H. R. MacDonald, J. Exp. Med. 182, 633 (1995).
24. S. T. Smiley and M. J. Grusby, data not shown.
25. A. Zlotnik, D. I. Godfrey, M. Fischer, T. Suda, J. Immunol. 149, 1211 (1992).
26. D. R. Brown et al., J. Exp. Med. 184, 1295 (1996); Y. Zhang, K. H. Rogers, D. B. Lewis, ibid., p. 1507.
27. D. R. Brown et al., J. Exp. Med. 184, 1295 (1996); Y. Zhang, K. H. Rogers, D. B. Lewis, ibid., p. 1507.
28. P. A. Bleicher et al., Science 250, 679 (1990).
29. S. P. Balk, P. A. Bleicher, C. Terhorst, J. Immunol. 146, 768 (1991).
30. 5 thymocytes from the indicated mice in 96-well microcultures. After 24 hours, supernatants were harvested, and IL-2 production was quantitated by HT-2 cell proliferation. Proliferation was converted to IL-2 units with the use of a standard curve generated with recombinant IL-2 (Genzyme).
31. -/loW thymocytes were obtained by treatment of total thymocytes with antibody to HSA (clone J11d2) plus rabbit complement (Cederlane, Hornby, Ontario, Canada) for 45 min at 37°C, followed by isolation of viable cells on lympholyte M gradients (Cederlane). After Fc receptors were blocked by treatment with mAb 24G2, cells were stained with phycoerythrin-conjugated mAb specific for VβS.8.1/8.2 and fluorescein-conjugated mAb specific for NK1.1 or CD44, and then analyzed by flow cytometry. All mAbs were purchased from Pharmingen.
32. -/low thymocytes in 1 ml of media. After 48 hours, supernatants were harvested and assayed for cytokine production (2). Recombinant IL-4 and IFN-γ (Genzyme) were used to generate standard curves.
33. 2M-deficient BALB/c mice, T. Laufer for help with intravenous injections, and K. Sahmel for technical assistance. Supported by a grant from NIH to M.J.G. (RO1 AI40171) and a gift from the Mathers Foundation.